250 related articles for article (PubMed ID: 11257047)
1. In vitro and in vivo combinations of cefotaxime and minocycline against Aeromonas hydrophila.
Ko WC; Lee HC; Chuang YC; Ten SH; Su CY; Wu JJ
Antimicrob Agents Chemother; 2001 Apr; 45(4):1281-3. PubMed ID: 11257047
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.
Ko WC; Chiang SR; Lee HC; Tang HJ; Wang YY; Chuang YC
Antimicrob Agents Chemother; 2003 Jul; 47(7):2217-22. PubMed ID: 12821471
[TBL] [Abstract][Full Text] [Related]
3. Synergistic antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infection.
Chiang SR; Tang HJ; Chang PC; Cheng KC; Ko WC; Chen CH; Chuang YC
J Microbiol Immunol Infect; 2007 Apr; 40(2):123-33. PubMed ID: 17446960
[TBL] [Abstract][Full Text] [Related]
4. Cefazolin plus minocycline against a clinical isolate of Vibrio vulnificus: in vitro and animal studies.
Tang HJ; Ko WC; Chuang YC; Chen CC; Chiang SR
Jpn J Infect Dis; 2010 Jan; 63(1):16-8. PubMed ID: 20093756
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antibacterial activity of tigecycline against Vibrio vulnificus.
Tang HJ; Chen CC; Lai CC; Zhang CC; Weng TC; Chiu YH; Toh HS; Chiang SR; Yu WL; Ko WC; Chuang YC
J Microbiol Immunol Infect; 2018 Feb; 51(1):76-81. PubMed ID: 27260781
[TBL] [Abstract][Full Text] [Related]
6. In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus.
Chuang YC; Liu JW; Ko WC; Lin KY; Wu JJ; Huang KY
Antimicrob Agents Chemother; 1997 Oct; 41(10):2214-7. PubMed ID: 9333050
[TBL] [Abstract][Full Text] [Related]
7. In vitro antimicrobial effect of cefazolin and cefotaxime combined with minocycline against Vibrio cholerae non-O1 non-O139.
Su BA; Tang HJ; Wang YY; Liu YC; Ko WC; Liu CY; Chuang YC;
J Microbiol Immunol Infect; 2005 Dec; 38(6):425-9. PubMed ID: 16341343
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis.
Petersen PJ; Labthavikul P; Jones CH; Bradford PA
J Antimicrob Chemother; 2006 Mar; 57(3):573-6. PubMed ID: 16431863
[TBL] [Abstract][Full Text] [Related]
9. [Bacteremic peritonitis caused by Aeromonas hydrophila in a woman with cirrhosis].
Ramos Rincón JM; Esteban Moreno J; Cuenca Estrella M; Nuñez García A
An Med Interna; 1996 Mar; 13(3):154. PubMed ID: 8679853
[No Abstract] [Full Text] [Related]
10. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Cha R
Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
[TBL] [Abstract][Full Text] [Related]
11. Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies.
Entenza JM; Moreillon P
Int J Antimicrob Agents; 2009 Jul; 34(1):8.e1-9. PubMed ID: 19162449
[TBL] [Abstract][Full Text] [Related]
12. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
Tan TY; Ng LS; Tan E; Huang G
J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671
[TBL] [Abstract][Full Text] [Related]
13. In vitro efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus.
Kim DM; Lym Y; Jang SJ; Han H; Kim YG; Chung CH; Hong SP
Antimicrob Agents Chemother; 2005 Aug; 49(8):3489-91. PubMed ID: 16048966
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus.
Tang HJ; Chang MC; Ko WC; Huang KY; Lee CL; Chuang YC
Antimicrob Agents Chemother; 2002 Nov; 46(11):3580-4. PubMed ID: 12384368
[TBL] [Abstract][Full Text] [Related]
15. The activity of ceftiofur sodium for Aeromonas spp. isolated from ornamental fish.
Dixon BA; Issvoran GS
J Wildl Dis; 1992 Jul; 28(3):453-6. PubMed ID: 1512880
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial effect of Cu2+-exchanged montmorillonite on Aeromonas hydrophila and discussion on its mechanism.
Hu CH; Xu ZR; Xia MS
Vet Microbiol; 2005 Aug; 109(1-2):83-8. PubMed ID: 15939555
[TBL] [Abstract][Full Text] [Related]
17. [Kinetics of bactericidial function of cefotaxim against Pseudomonas aeruginosa alone and in combination with tobramycin].
Shah PM; Troche G; Stille W
Med Welt; 1980 Aug; 31(35):1244-5. PubMed ID: 6252415
[No Abstract] [Full Text] [Related]
18. Aspects of constitutive and acquired antibioresistance in Aeromonas hydrophila strains isolated from water sources.
Balotescu C; Israil A; Radu R; Alexandru I; Dobre G
Roum Arch Microbiol Immunol; 2003; 62(3-4):179-89. PubMed ID: 16008142
[TBL] [Abstract][Full Text] [Related]
19. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
Rodríguez-Cerrato V; García P; Del Prado G; García E; Gracia M; Huelves L; Ponte C; López R; Soriano F
J Antimicrob Chemother; 2007 Nov; 60(5):1159-62. PubMed ID: 17827138
[TBL] [Abstract][Full Text] [Related]
20. Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro.
Lin E; Stanek RJ; Mufson MA
Antimicrob Agents Chemother; 2003 Mar; 47(3):1151-3. PubMed ID: 12604560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
